Olubanke Olujoke Ogunlana
About me
Olubanke Olujoke Ogunlana, Ph.D. is a Professor of Biochemistry at Covenant University, Ota, Nigeria. She specializes in molecular pharmacology, drug discovery, clinical biochemistry, and toxicology, with research focused on advancing solutions to global health challenges. A recipient of awards from the Chinese Academy of Sciences/TWAS and AstraZeneca/IUTOX/SOT, she has held leadership roles including Head of the Biochemistry Department and Chair of the University Quality Assurance and Academic Standards Committee. She also serves as Monitoring and Evaluation Officer at the World Bank–funded Covenant Applied Informatics and Communication Africa Centre of Excellence (CApIC-ACE). Prof. Ogunlana is Editor-in-Chief of the Covenant Journal of Health and Life Sciences and an active member of several international professional bodies. Her work bridges academia and industry while mentoring the next generation of scientists and leaders.
Olubanke Olujoke Ogunlana is a Professor of Biochemistry at Covenant University, Ota, Ogun State, Nigeria, where she passionately drives excellence in research, teaching, and leadership. A scholar with an illustrious academic journey, she earned her Bachelor’s degree in Biochemistry from Obafemi Awolowo University, Ile-Ife, followed by a Master’s degree in Pharmaceutical Chemistry from the University of Ibadan and a Ph.D. in Biochemistry from Covenant University. Prof. Ogunlana's research embodies a fervent dedication to advancing knowledge in molecular pharmacology, drug discovery, clinical biochemistry, and toxicology, and her insights have shaped innovative solutions to pressing global health challenges. Her unwavering commitment to excellence has seen her serve as the Head of the Biochemistry Department and currently as the Chair of the University Quality Assurance and Academic Standards Committee, a role in which she inspires transformative standards of academic and institutional growth.
Her achievements are as remarkable as they are inspiring. Prof. Ogunlana is a proud recipient of the 2009 Chinese Academy of Sciences (CAS) and Academy of Sciences for the Developing World (TWAS) award and the 2013 AstraZeneca/International Union of Toxicology (IUTOX)/Society of Toxicology (SOT) Travel Fellowship, joining an elite cadre of scholars at the 52nd SOT Annual Meeting in San Antonio, Texas, USA, among other accolades. As the Monitoring and Evaluation Officer and a researcher at the Covenant Applied Informatics and Communication Africa Centre of Excellence (CApIC-ACE), a prestigious World Bank-funded Center of Excellence, she continues to champion impactful research, bridging the gap between academia and industry to solve complex societal problems.
Prof. Ogunlana is a distinguished member of several leading professional organisations, including the American Society of Biochemistry and Molecular Biology (USA), Society of Toxicology (USA), Women in Toxicology (USA), Nigerian Society of Biochemistry and Molecular Biology (Nigeria), and Covenant University Faculty Women Advance (Nigeria). As the Editor-in-Chief of the Covenant Journal of Health and Life Sciences, she curates groundbreaking scientific discourse, fostering collaboration and innovation among researchers worldwide.
Her academic contributions are captured in numerous peer-reviewed publications in local and international journals, testifying to her thought leadership and intellectual depth. Beyond her professional life, Prof. Ogunlana is deeply devoted to her family, sharing a beautiful life with her husband, Mr. Oluseyi E. Ogunlana, and their three wonderful children.
With an unyielding passion for problem-solving and a heart for mentoring, Prof. Ogunlana leverages her narratives, experiences, and expertise to empower others, creating pathways for success and inspiring the next generation of leaders to thrive.
Degrees:
(2) Ogunlana OO, Adetuyi BO, Adekunbi TS, Adegboye BE, Iheagwam FN, Ogunlana OE (2021) Ameliorative effect of Ruzu herbal bitters on high-fat diet induced non-alcoholic fatty liver disease in Wistar rats. Journal of Pharmacy and Pharmacognosy Research 9(3): 251–260. Impact Factor of 0.18
(3) Adetuyi, B.O., Adebisi, O.A., Awoyelu, E.H., Adetuyi, O.A. and Ogunlana, O.O., (2021) Phytochemical and Toxicological Effect of Ethanol Extract of Heliotropium Indicum on Liver of Male Albino Rats. Letters in Applied Bioscience. 10(2): 2085 – 2095.
(4) Odutayo, O.E., Omonigbehin, E.A., Olawole, T.D., Ogunlana, O.O. and Afolabi, I.S., 2020. Fermentation Enhanced Biotransformation of Compounds in the Kernel of Chrysophyllum albidum. Molecules, 25(24), p.6021. Impact Factor of 0.7
(5) Oluwafemi Adetuyi, B., Olamide Okeowo, T., Adefunke Adetuyi, O., Abraham Adebisi, O., Ogunlana, O.O., Janet Oretade, O., Marraiki, N., Beshbishy, A.M., N Welson, N. and Batiha, G.E.S. (2020). Ganoderma Lucidum from Red Mushroom Attenuates Formaldehyde-Induced Liver Damage in Experimental Male Rat Model. Biology, 9(10), p.313. Impact Factor of 1.74
(6) Adedeji, E.O., Ogunlana, O.O., Fatumo, S. Thomas Beder, Yvonne Ajamma, Rainer Koenig and Ezekiel Adebiyi (2020). Anopheles metabolic proteins in malaria transmission, prevention and control: a review. Parasites Vectors 13, 465. https://doi.org/10.1186/s13071-020-04342-5. Impact Factor of 1.41
(7) Olubanke O. Ogunlana, Oluseyi E. Ogunlana, Tobi S. Adekunbi, Babatunde O. Adetuyi, Bose E. Adegboye, and Franklyn N. Iheagwam (2020). Anti-inflammatory Mechanism of Ruzu Bitters on Diet-Induced Nonalcoholic Fatty Liver Disease in Male Wistar Rats. Evidence-Based Complementary and Alternative Medicine, 2020 https://doi.org/10.1155/2020/5246725. Impact Factor of 0.51
(8) Iheagwam F.N., Israel E.N., Kayode K.O., De Campos O.C., Ogunlana O.O. and Chinedu S.N. (2020). Nauclea latifolia Sm. Leaf Extracts Extenuates Free Radicals, Inflammation, and Diabetes-Linked Enzymes. Oxidative Medicine and Cellular Longevity. Special Issue: The Interplay of Oxidative Stress and Inflammation: Mechanistic Insights and Therapeutic Potential of Antioxidants. Volume 2020, Article ID: 5612486, 13 pages. https://doi.org/10.1155/2020/5612486 , http://downloads.hindawi.com/journals/omcl/2020/5612486.pdf. Impact Factor of 1.39
(9) Iheagwam, F.N., Israel, E.N., Kayode, K.O., De Campos, O.C., Ogunlana, O.O. and Chinedu, S.N., 2019. GC-MS Analysis and Inhibitory Evaluation of Terminalia catappa Leaf Extracts on Major Enzymes Linked to Diabetes. Evidence-Based Complementary and Alternative Medicine, 2019. Impact Factor of 0.51
(10) Iheagwam, F.N., Ogunlana, O.O. and Chinedu, S.N., 2019. Model Optimization and In Silico Analysis of Potential Dipeptidyl Peptidase IV Antagonists from GC-MS Identified Compounds in Nauclea latifolia Leaf Extracts. International journal of Molecular Sciences, 20(23), p.5913. Impact Factor of 1.32
(11) Popoola, J.O., Egwari, L.O., Adekunle, A., Ogunlana, O.O. and Omonhinmin, C.A., 2019. Genetic Variability and Development of Cassava Based Products Using Morphometric and RAPD Markers. Asian Journal of Plant Sciences, 18, pp.26-32. Impact Factor of 0.29
(12) Iheagwam, F.N., Okeke, C.O., DeCampos, O.C., Okere, D.U., Ogunlana, O.O. and Chinedu, S.N., 2019, August. Safety evaluation of Terminalia catappaLinn (Combretaceae) aqueous leaf extract: Sub-acute cardio-toxicopathological studies in albino Wistar rats. In Journal of Physics: Conference Series (Vol. 1299, No. 1, p. 012109). IOP Publishing.
(13) Iheagwam, F.N., Ogunlana, O.O., Ogunlana, O.E., Isewon, I. and Oyelade, J. (2019). Potential anti-cancer flavonoids isolated from Caesalpinia bonduc young twigs and leaves: molecular docking and in silico studies. Bioinformatics and Biology Insights, 13, p.1177932218821371. Impact Factor of 0.97